Dluzynski, D., Ssentongo, P., Hale, C. M., Shaheen, S. K., Maglakelidze, N., Sivik, J. M., Henao, M. P., Chinchilli, V. M., Paules, C. I. (2025). Dose-dependent impact of tixagevimab–cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals. Scientific Reports. https://doi.org/10.1038/s41598-025-02240-3